Snorting Miralax is Dangerous and Should Never Be Done
Do not snort Miralax (polyethylene glycol 3350) under any circumstances - this medication is FDA-approved only for oral administration when dissolved in liquid, and intranasal use poses serious risks to nasal mucosa, respiratory tract, and potentially systemic complications.
Why This is Harmful
Approved Route of Administration
Miralax is specifically formulated and FDA-approved as an oral osmotic laxative that must be dissolved in 8 ounces (approximately 240 mL) of liquid before consumption 1. The medication works by drawing water into the colon through osmotic action when taken orally - this mechanism cannot function through nasal administration.
Specific Dangers of Intranasal Use
Direct tissue damage:
- The powder will cause immediate irritation and potential chemical injury to the delicate nasal mucosa
- Risk of nasal septum perforation with repeated use
- Potential aspiration into lungs causing chemical pneumonitis
- Damage to sinus cavities and olfactory structures
Systemic risks:
- While oral PEG 3350 is generally safe with minimal systemic absorption, intranasal administration bypasses normal gastrointestinal processing
- Case reports exist of PEG 3350 contamination with ethylene glycol causing severe toxicity including acute kidney injury, high anion gap metabolic acidosis, and calcium oxalate crystal nephropathy 2
- Direct absorption through damaged nasal mucosa could theoretically increase systemic exposure
No therapeutic benefit:
- PEG 3350 functions as an osmotic laxative in the gastrointestinal tract - it has zero therapeutic effect when administered intranasally
- The medication requires oral ingestion to reach the colon where it exerts its laxative effect 3
Proper Use of Miralax
If constipation treatment is needed, Miralax should be used correctly:
- Dose: 17 g (one capful or packet) dissolved in 8 ounces of any beverage
- Frequency: Once daily
- Duration: Effective and safe for up to 6-12 months of continuous use 3, 4
- Efficacy: Increases complete spontaneous bowel movements by approximately 2.9 per week compared to placebo 3
- Safety profile: Common side effects when used orally include mild diarrhea, bloating, flatulence, and nausea - all gastrointestinal and generally mild 3
Critical Clinical Considerations
If someone has snorted Miralax:
- Assess for immediate nasal irritation, bleeding, or respiratory distress
- Monitor for signs of aspiration (cough, dyspnea, chest pain)
- Consider nasal irrigation with saline if recent exposure
- Evaluate for substance misuse disorder if this represents intentional drug misuse behavior
- Screen for underlying psychiatric conditions or self-harm behaviors
Red flags requiring immediate evaluation:
- Respiratory symptoms suggesting aspiration
- Severe nasal bleeding
- Signs of systemic toxicity (altered mental status, metabolic acidosis) - though unlikely from isolated intranasal exposure
There is absolutely no legitimate medical indication for intranasal administration of polyethylene glycol 3350. This represents either a dangerous misunderstanding of medication use or potential substance misuse requiring appropriate intervention.